Institute of Public Health, University of Heidelberg, Germany.
Oral Oncol. 2011 Dec;47(12):1154-8. doi: 10.1016/j.oraloncology.2011.08.003. Epub 2011 Aug 27.
Survival in patients with laryngeal cancer has not increased remarkably within the last years. It is presumed that a variety of factors act jointly in predicting survival after diagnosis: tumour stage, tumour site, treatment approaches, age and comorbidities. The aim of this German clinical multi-centre study is to present results from multivariate analysis. A retrospective cohort study was conducted in four hospitals in South-West Germany. Incident cases with laryngeal squamous cell carcinoma were included for the years 1998 to 2004, resulting in a population sample of 594 patients. Multivariate regression analysis was performed using the Cox proportional hazards model. Patients were followed up for 64.1months on average. Overall 5-year survival was 66% (95% confidence interval (CI): 62-70%). The strongest risk factors in multivariate analysis were age at first diagnosis (hazard ratio (HR): 1.5; 95% CI: 1.5-1.7 per each additional 10years), tumour stage, and the development of recurrences (HR 3.1; 95% CI: 2.3-4.2) or second primary carcinomas (HR 2.1; 95% CI: 1.4-3.1). A somewhat weaker effect was shown for patients with comorbidities (using Charlson's comorbidity index). The choice of treatment did not strongly affect survival when adjusting for other factors, possibly because the optimal treatment approach was applied for the specific constitution and requirements of each patient. For future research it would be desirable to study the effect of treatment on quality of life in multivariate analysis as well as other modifiable risk factors as smoking and drinking reduction or cessation after diagnosis.
近年来,喉癌患者的生存率并没有显著提高。据推测,多种因素共同作用于诊断后的生存预测:肿瘤分期、肿瘤部位、治疗方法、年龄和合并症。这项德国临床多中心研究的目的是展示多变量分析的结果。在德国西南部的四家医院进行了一项回顾性队列研究。纳入了 1998 年至 2004 年患有喉鳞状细胞癌的发病病例,共纳入 594 例患者。使用 Cox 比例风险模型进行多变量回归分析。患者平均随访 64.1 个月。总 5 年生存率为 66%(95%置信区间:62-70%)。多变量分析中最强的危险因素是首次诊断时的年龄(风险比(HR):每增加 10 岁,HR:1.5;95%置信区间:1.5-1.7)、肿瘤分期以及复发(HR:3.1;95%置信区间:2.3-4.2)或第二原发癌(HR:2.1;95%置信区间:1.4-3.1)的发展。患有合并症的患者(使用 Charlson 合并症指数)的风险略低。在调整其他因素后,治疗方法的选择对生存的影响并不强烈,这可能是因为针对每个患者的具体情况和需求选择了最佳的治疗方法。在未来的研究中,理想情况下应在多变量分析中研究治疗对生活质量的影响以及其他可改变的危险因素,如吸烟和饮酒减少或诊断后戒烟。